Concepedia

Publication | Open Access

Phase (Ph) II study of MBG453 + spartalizumab in patients (pts) with non-small cell lung cancer (NSCLC) and melanoma pretreated with anti–PD-1/L1 therapy

28

Citations

0

References

2019

Year

No additional data available for this publication yet. Check back later!